Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer
- PMID: 24972610
- PMCID: PMC4079912
- DOI: 10.1186/1471-2407-14-472
Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer
Abstract
Background: Matrix metalloproteinases (MMPs) are involved in cancer invasion and metastasis. Circulating tumor cells (CTCs) play role in tumor dissemination and are an independent survival predictor in breast cancer (BC) patients. The aim of this study was to assess correlation between CTCs and tumor MMP1 in BC.
Methods: Study included 149 primary BC patients treated by surgery from March 2012 to March 2013. Peripheral blood mononuclear cells (PBMC) were depleted of hematopoietic cells using RossetteSep(TM) selection kit. RNA extracted from CD45-depleted PBMC was interrogated for expression of EMT (TWIST1, SNAIL1, SLUG, ZEB1) and epithelial (CK19) gene transcripts by qRT-PCR. Patient samples with higher epithelial and/or mesenchymal gene transcripts than those of healthy donors (n = 60) were considered as CTC positive. Expression of MMP1 in surgical specimens was evaluated by immunohistochemistry.
Results: CTCs were detected in 24.2% patients. CTCs exhibiting only epithelial markers were present in 8.7% patients, whereas CTCs with epithelial-mesenchymal transition (EMT) markers (CTC_EMT) were observed in 13.4% of patients and CTCs co-expressing both markers were detected in 2.0% patients. Patients with CTC_EMT in peripheral blood had significantly increased expression of MMP1 in tumor cells (p = 0.02) and tumor associated stroma (p = 0.05) than those of patients without CTC_EMT. In multivariate analysis, CTC_EMT and tumor grade were independently associated with MMP1 expression in cancer cells, while CTC_EMT and Ki67 were independently associated with MMP1 expression in cancer associated stroma.
Conclusion: Our data suggest link between MMP1 and CTCs with EMT phenotype and support role of MMPs and EMT in tumor dissemination.
Figures
Similar articles
-
Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.BMC Cancer. 2015 Jul 22;15:533. doi: 10.1186/s12885-015-1548-7. BMC Cancer. 2015. PMID: 26194471 Free PMC article.
-
CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancer.BMC Cancer. 2016 Feb 19;16:127. doi: 10.1186/s12885-016-2143-2. BMC Cancer. 2016. PMID: 26896000 Free PMC article.
-
Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.Mol Cancer Ther. 2012 Nov;11(11):2526-34. doi: 10.1158/1535-7163.MCT-12-0460. Epub 2012 Sep 12. Mol Cancer Ther. 2012. PMID: 22973057 Free PMC article.
-
Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.Adv Clin Chem. 2018;83:121-181. doi: 10.1016/bs.acc.2017.10.004. Epub 2017 Dec 21. Adv Clin Chem. 2018. PMID: 29304900 Review.
-
Expression of Epithelial Mesenchymal Transition and Cancer Stem Cell Markers in Circulating Tumor Cells.Adv Exp Med Biol. 2017;994:205-228. doi: 10.1007/978-3-319-55947-6_11. Adv Exp Med Biol. 2017. PMID: 28560676 Review.
Cited by
-
Vitamin D and circulating tumor cells in primary breast cancer.Front Oncol. 2022 Sep 7;12:950451. doi: 10.3389/fonc.2022.950451. eCollection 2022. Front Oncol. 2022. PMID: 36158648 Free PMC article.
-
Extracellular vesicles produced in B cells deliver tumor suppressor miR-335 to breast cancer cells disrupting oncogenic programming in vitro and in vivo.Sci Rep. 2018 Dec 4;8(1):17581. doi: 10.1038/s41598-018-35968-2. Sci Rep. 2018. PMID: 30514916 Free PMC article.
-
MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors in vitro.Oncol Lett. 2019 Feb;17(2):1732-1740. doi: 10.3892/ol.2018.9779. Epub 2018 Nov 30. Oncol Lett. 2019. PMID: 30675232 Free PMC article.
-
Circulating tumor cells and breast cancer-specific mutations in primary breast cancer.Mol Clin Oncol. 2020 Jun;12(6):565-573. doi: 10.3892/mco.2020.2026. Epub 2020 Apr 1. Mol Clin Oncol. 2020. PMID: 32337039 Free PMC article.
-
Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer.Cancers (Basel). 2020 May 1;12(5):1134. doi: 10.3390/cancers12051134. Cancers (Basel). 2020. PMID: 32369910 Free PMC article.
References
-
- Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781–791. - PubMed
-
- Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol. 2012;13:688–695. - PubMed
-
- Zhang L, Riethdorf S, Wu G, Wang T, Yang K, Peng G, Liu J, Pantel K. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res. 2012;18:5701–5710. - PubMed
-
- Zhao S, Liu Y, Zhang Q, Li H, Zhang M, Ma W, Zhao W, Wang J, Yang M. The prognostic role of circulating tumor cells (CTCs) detected by RT-PCR in breast cancer: a metaanalysis of published literature. Breast Cancer Res Tr. 2011;130:809–816. - PubMed
-
- Mego M, Mani SA, Cristofanilli M. Molecular mechanisms of metastasis in breast cancer-clinical applications. Nat Rev Clin Oncol. 2010;7:693–701. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous